(Q34348231)

1 August 2017

title

Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome (English)

1 reference

1 August 2017

Graeme E Correll

1

1 reference

1 August 2017

Jahangir Maleki

2

1 reference

1 August 2017

Edward J Gracely

3

1 reference

1 August 2017

Jesse J Muir

4

1 reference

1 August 2017

Ronald E Harbut

5

1 reference

1 August 2017

publication date

1 September 2004

1 reference

1 August 2017

1 reference

1 August 2017

volume

5

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

263-275

1 reference

Successful treatment of a nine-year case of complex regional pain syndrome type-I (reflex sympathetic dystrophy) with intravenous ketamine-infusion therapy in a warfarin-anticoagulated adult female patient.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Spinal cord synaptic plasticity and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Automatic and strategic processing of threat cues in patients with chronic pain: a modified stroop evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Update on the neurophysiology of pain transmission and modulation: focus on the NMDA-receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

The induction and maintenance of central sensitization is dependent on N -methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Targeting the N-methyl-D-aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Low dose intravenous infusion technique with ketamine. Amnesic, analgesic and sedative effects in human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Post-operative pain relief with ketamine infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Response of chronic neuropathic pain syndromes to ketamine: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Four years' treatment with ketamine and a trial of dextromethorphan in a patient with severe post-herpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Oral ketamine therapy in the treatment of postamputation stump pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

An unusual case of chronic neuropathic pain responds to an optimum frequency of intravenous ketamine infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Hydromorphone-3-glucuronide: a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Morphine-3beta-D-glucuronide suppresses inhibitory synaptic transmission in rat substantia gelatinosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Morphine-3-glucuronide's neuro-excitatory effects are mediated via indirect activation of N-methyl-D-aspartic acid receptors: mechanistic studies in embryonic cultured hippocampal neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

NMDA Antagonist Neurotoxicity: Mechanism and Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

A comparative evaluation of the neurotoxic properties of ketamine and nitrous oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Multifocal brain damage induced by phencyclidine is augmented by pilocarpine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Dexmedetomidine premedication attenuates ketamine-induced cardiostimulatory effects and postanesthetic delirium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Effects of oral clonidine premedication on side effects of intravenous ketamine anesthesia: a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Excessive cerebrocortical release of acetylcholine induced by NMDA antagonists is reduced by GABAergic and alpha2-adrenergic agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Analysis of drug interaction between intrathecal clonidine and MK-801 in peripheral neuropathic pain rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

Clonidine potentiates the neuropathic pain-relieving action of MK-801 while preventing its neurotoxic and hyperactivity side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2004.04043.X

10.1111/J.1526-4637.2004.04043.X

21 January 2018

Identifiers

DOI

1 reference

release_hhbtzqgfsfbszeckqrs5zsjuty

1 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hhbtzqgfsfbszeckqrs5zsjuty

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference